The latest report on Neurodiagnostics Market by Infinium Global Research gives complete coverage of the neurodiagnostics market by technology type (neuroimaging, in vitro diagnosis), disease type (migraine, multiple sclerosis, alzheimer’s disease), end-user (diagnostic laboratories and imaging centers, hospitals and surgical centers, ambulatory care centers) in terms of key trends, market size, forecast and CAGR growth over the period of 2019 to 2025. In addition, the study covers deep dive into key product and applications trends in the regional markets of neurodiagnostics such as North America, Europe, Asia-Pacific and Latin America over the short run and long run. The global neurodiagnostics market is projected to grow at a CAGR of 8.3% over the forecast period of 2019-2025.
Get Sample Report Copy for Market Insights @ https://www.infiniumglobalresearch.com/reports/sample-request/18791
Rising Prevalence of Neurological Diseases and Disorders will Augment the Growth of the Neurodiagnostics Market
Neurodiagnostics monitors and records the electrical activities of the patient’s brain, peripheral nerves, and spinal cord. As per the World Health Organization, one in four people globally gets affected by a mental or neurological disorder. This stimulates the need for a diagnosis of common neurological disorders.
The rising prevalence of neurological diseases and disorders will augment the growth of the neurodiagnostics market. A study estimated that globally in 2016 neurological disorders were the leading cause of disability-adjusted life year that is around 276 million and the second leading cause of deaths that accounted for 9.0 million. The growing advancement in genomics and proteomics for the diagnosis of neurodegenerative disorders contribute to the expansion of the neurodiagnostics market. Further, the rising adoption of effective and early disease diagnosis led to a rise in demand for neurodiagnostics.
Rising Applications in Clinical Trials Create Numerous Opportunities for the Growth of the Neurodiagnostics Market
Additionally, the prevalence of various diseases such as strokes, sleep disorders, narcolepsy, and multiple sclerosis boosts the demand for neurodiagnostics. A study estimated that there are around 44 million people globally having Alzheimer’s disease. Parkinson’s is the second most common neurodegenerative disorder after Alzheimer’s disease among the aging population. As per a study around 7 to 10 million people globally have Parkinson’s disease. The prevalence of this disease ranges from 41 people per 100000 in the fourth decade of life to more than 1900 individuals per 100000 among those aged 80 and above.
Additionally, dementia is also one of the prevailing neurological disorders. As per the World Health Organization, there are around 50 million people suffering from dementia and nearly 10 million new cases are generated every year. On the flip side, the high cost of neurodiagnostics devices hinders the growth of the neurodiagnostics market. Moreover, rising applications in clinical trials create numerous opportunities for the growth of the neurodiagnostics market.
North America is Anticipated to Have a Premium Share in the Global Neurodiagnostics Market
Geographically, the global neurodiagnostics market is divided into North America, Europe, Asia-Pacific, and the Rest of the World. North America is anticipated to have a premium share in the global neurodiagnostics market. The well-established healthcare infrastructure, the prevalence of neurological disorders, and the growing adoption of advanced neurodiagnostics tools in North America contribute to the expansion of the neurodiagnostics market in North America. A study estimated that in the United States around 5.5 million people have Alzheimer’s disease. Asia-Pacific region is expected to grow with the fastest CAGR in the global neurodiagnostics market over the forecast period. The rising patient pool and a surge in healthcare expenditure in the region will augment the growth of the neurodiagnostics market in Asia-Pacific. Europe has fruitful growth opportunities in the global neurodiagnostics market due to the growing healthcare industry in the region.
Table of Content
Chapter – 1 Preface
Chapter – 2 Executive Summary
Chapter – 3 Global Neurodiagnostics Market Overview
Chapter – 4 Neurodiagnostics Market Macro Indicator Analysis
Chapter – 5 Global Neurodiagnostics Market by Technology Type
- Nuclear Medicine Imaging
- Other Neuroimaging Technologies
- In Vitro Diagnosis
- Genetic Testing
- Protein Biomarker Assay
- Other in Vitro Diagnosis
Chapter – 6 Global Neurodiagnostics Market by Disease Type
- Multiple Sclerosis
- Alzheimer’s Disease
- Parkinson’s Disease
- Other Diseases
Chapter – 7 Global Neurodiagnostics Market by End-user
- Neurology Centers
- Diagnostic Laboratories and Imaging Centers
- Hospitals and Surgical Centers
- Ambulatory Care Centers
- Research Laboratories
Chapter – 8 Global Neurodiagnostics Market by Region 2019-2025
- North America
Chapter – 9 Company Profiles and Competitive Landscape
- Ridge Diagnostics, Inc.
- Zynex NeuroDiagnostics, Inc.
- Digital NeuroDiagnostics, LLC
- NeuroDiagnostics Devices Inc.
- Lifelines Neurodiagnostics Systems Inc.
- GE Healthcare
- Siemens Healthineers AG
- Canon, Inc.
- Hoffmann-La Roche AG
- Mitsar Co., Ltd.
Chapter – 10 Appendix
- Primary Research Findings and Questionnaire
Browse Detailed TOC and Description of this Exclusive [email protected] https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-neurodiagnostics-market
About Infinium Global Research
Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes and non-profit/non-government organizations to meet their knowledge and information needs.
Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide the knowledge support to our clients. To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations and environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.